MOESM1 of Inhibition LC3B can increase chemosensitivity of ovarian cancer cells

Additional file 1: Table S1. Summary of Ovarian cancer Patient’s Clinical and Pathologic Features. Table S2. Samples of EOC ascites and tissues. Table S3. Sequences of primers used for quantitative real-time-PCR. Table S4. List of primary antibodies used in western blotting. Table S5. Dates of luciferase reporter assay.